Skip to Content

The Trendlines Group Ltd ADR TRNLY

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

The Trendlines Group Ltd creates and develops companies to improve the human condition. The company is a commercialization company. It invents, discovers, invests in, and incubates medical and agricultural technologies. It is also involved in all aspects of portfolio companies from technology development to business building. The company invests through its incubators: The two Israeli government-franchised incubators, Trendlines Medical and Trendlines Agtech, The Singapore incubator, Trendlines Medical Singapore, and its in-house innovation center, Trendlines Labs.

Contact
17 T’chelet Street, Misgav Business Park
M.P. Misgav, 2017400, Israel
T +972 722607000
Sector Financial Services
Industry Asset Management
Most Recent Earnings Dec 31, 2019
Fiscal Year End Dec 31, 2019
Stock Type
Employees 39